<DOC>
	<DOCNO>NCT00412607</DOCNO>
	<brief_summary>The primary objective provide additional corroborative safety efficacy data Navistar ThermoCool catheter treatment subject ischemic Ventricular Tachycardia .</brief_summary>
	<brief_title>Catheter Evaluation Endocardial Ablation Patients With Ventricular Tachycardia</brief_title>
	<detailed_description>This study prospective , non-randomized , single-arm , multi-center condition approval evaluation . The device currently FDA approve commercial distribution . Subjects ischemic ventricular tachycardia consider condition approval study . This study conduct 30 center minimum 249 evaluable subject .</detailed_description>
	<mesh_term>Tachycardia</mesh_term>
	<mesh_term>Tachycardia , Ventricular</mesh_term>
	<criteria>1 . Documented spontaneous episode sustain ventricular tachycardia ( must satisfy one ) 1 . For patient ICDs : Documented episode must four ( 4 ) great entry study . 2 . For patient without ICDs : Documented episode must two ( 2 ) great within two ( 2 ) month assessment perform review ECGs hospitalization record . 3 . Incessant VT due prior myocardial infarction ( define present one ( 1 ) hour refractory immediately recurrent administration antiarrhythmic medication cardioversion ) . 2 . Spontaneous occurrence symptomatic ventricular tachycardia despite antiarrhythmic drug therapy ICD intervention . 3 . Left ventricular ejection fraction &gt; 10 % estimate echocardiography , contrast ventriculography radionuclide image within previous ninety ( 90 ) day . 4 . Age eighteen ( 18 ) year older . 5 . Signed Patient Informed consent form . 6 . Able willing comply pre , post , followup testing requirement . 1 . Definite protruding leave ventricular thrombus preablation echocardiogram . 2 . Myocardial infarction within precede two ( 2 ) month . Patients incessant VT ( define present one ( 1 ) hour refractory immediately recurrent administration antiarrhythmic medication cardioversion ) may enrol MI least three ( 3 ) week old . 3 . Patients idiopathic VT. 4 . Other disease process likely limit survival less twelve ( 12 ) month . 5 . Class IV heart failure . 6 . Serum creatinine &gt; 2.5 mg/dl . 7 . Thrombocytopenia ( define platelet count &lt; 80,000 ) coagulopathy . 8 . Contraindication heparin . 9 . Women pregnant . 10 . Cardiac surgery ( i.e . ventriculotomy , atriotomy ) within past two ( 2 ) month . Patients incessant VT ( present 50 % time intervention period &gt; 12 h ) may enrol surgery least three ( 3 ) week old . 11 . Acute illness active systemic infection . 12 . Unstable angina . 13 . Severe aortic stenosis flail mitral valve . 14 . Uncontrolled heart failure . 15 . Significant congenital anomaly medical problem , opinion Principal Investigator , would preclude enrollment study . 16 . Enrolled investigational study evaluate another device drug .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Ventricular Tachycardia</keyword>
	<keyword>Heart Diseases</keyword>
	<keyword>Arrhythmia</keyword>
</DOC>